Experience

Apollo Endosurgery to Be Acquired by Boston Scientific

February 1, 2023

Cooley advised Apollo Endosurgery, a medical device company, on its agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.

Read more

Related contacts

Mark Weeks
Partner, Palo Alto
Ben Beerle
Partner, San Francisco
Milson Yu
Partner, Palo Alto
John McKenna
Partner, Palo Alto
Matthew D. Silverman
Special Counsel, San Diego
Sangitha Palaniappa
Associate, Palo Alto
Megan Browdie
Partner, Washington DC
Ross Eberly
Partner, Los Angeles Santa Monica
Sarah Lightdale
Partner, New York
Pat Mitchell
Partner, Boston
Howard Morse
Partner, Washington DC
Jason Savich
Partner, San Francisco
Charity Williams
Partner, San Diego
Jeff Goldman
Special Counsel, Palo Alto
Christine Graham
Special Counsel, London
Natasha Leskovsek
Of Counsel, Washington DC
Rebecca Ross
Special Counsel, Washington DC
Stella Sarma
Special Counsel, Brussels
Karen Tsai
Special Counsel, Washington DC
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Selma Abdel-Qader
Associate, Brussels
Andrew Bae
Associate, Washington DC
Victoria Comesañas
Associate, Palo Alto
Jessica Dallas
Associate, Palo Alto
Katherine Denby
Associate, Washington DC
Zack Gong
Associate, Shanghai
Wyatt Kernell
Associate, New York
Kristina Krasnikova
Associate, Palo Alto
Daniel Lac
Associate, San Diego
Edmond Lay
Associate, San Diego
James Lin
Associate, New York
Amanda Pacheco
Associate, Palo Alto
Greg Reith
Associate, Washington DC
Erica Russell
Associate, San Francisco
Jennifer Shanley
Special Counsel, New York
Rubin Waranch
Associate, Washington DC
Katie Weeks
Associate, Palo Alto
Freddy Yip
Associate, Hong Kong
Jovian Marcelo
Associate, Palo Alto

Tmunity Therapeutics Agrees to Sell to Kite

December 28, 2022

Cooley advised Tmunity Therapeutics, a clinical-stage biotechnology company, on its agreement to sell to Kite, a global biopharmaceutical company. Partners Mark Weeks, Ben Beerle and Marya Postner led the Cooley team.

Read more

Related contacts

Mark Weeks
Partner, Palo Alto
Ben Beerle
Partner, San Francisco
Marya Postner
Partner, Palo Alto
Chen Chen
Associate, Palo Alto
Jenny Ge
Associate, San Francisco
Megan Browdie
Partner, Washington DC
Ross Eberly
Partner, Los Angeles Santa Monica
Todd Gluth
Partner, San Diego
Kate Hillier
Partner, Seattle
Phil Mitchell
Partner, New York
Howard Morse
Partner, Washington DC
David Walsh
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington DC
Stella Sarma
Special Counsel, Brussels
Andrew Bae
Associate, Washington DC
Baasit Bhutta
Associate, Palo Alto
Paula Fleckenstein
Associate, Reston
John Forrest
Associate, Boston
Joyce Li
Associate, Chicago
Lindsey O'Crump
Associate, Washington DC
Maya Rahwanji
Associate, New York
Patrick Sharma
Associate, Los Angeles Santa Monica
Rubin Waranch
Associate, Washington DC
Zimu Yang
Associate, Washington DC
Freddy Yip
Associate, Hong Kong

Related Practices & Industries

Rani Therapeutics – $73 Million IPO

July 31, 2021

Cooley advised Rani Therapeutics on its $73.3 million initial public offering of 6,666,667 shares of Class A common stock. Rani Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol RANI, is a clinical-stage biotherapeutics company focused on advancing technologies to enable the development of orally administered biologics. Partners Josh Seidenfeld, Mark Weeks, John McKenna and Charlie Kim led the Cooley team.

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Mark Weeks
Partner, Palo Alto
John McKenna
Partner, Palo Alto
Charlie Kim
Partner, San Diego
Marina Remennik
Special Counsel, Palo Alto
Alexa M. Smith (Ekman)
Associate, San Diego
Megan Ji
Associate, Seattle
Rachel Lydon
Associate, San Diego
Karen Gustavson
Associate, Seattle

Related Practices & Industries

Unchained Labs Agrees to Sell to The Carlyle Group

April 27, 2021

Cooley advised Unchained Labs on its agreement to sell to The Carlyle Group, a publicly traded global investment firm, for $435 million. Partners Mark Weeks, Anne Lieberman and Al Browne led the Cooley team advising Unchained Labs, a life sciences tools company focused on solving problems for biologics and gene therapy researchers. 

Read more

Related contacts

Mark Weeks
Partner, Palo Alto
Anne Lieberman
Partner, Los Angeles Santa Monica
Zachary Sonenshine
Associate, New York
Stephanie Gentile
Partner, New York
David Dalton
Associate, Los Angeles Santa Monica
Alfred Browne
Partner, Boston
William Corcoran
Of Counsel, Boston
Alexander Ellebracht
Associate, Palo Alto
Stella Sarma
Special Counsel, Brussels
Julia R. Brinton
Associate, Washington DC
David Silverman
Partner, New York
Megan Browdie
Partner, Washington DC
Alessandra Murata
Partner, Palo Alto
Georgina Dietrich
Associate, Brussels
Joshua Elefant
Associate, Palo Alto
Joshua Mates
Partner, San Francisco

Related Practices & Industries

NeuroPace – $117 Million IPO

April 21, 2021

Cooley advised NeuroPace on its $117.3 million initial public offering of 6,900,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. NeuroPace, whose securities now trade on the Nasdaq Global Market under the symbol NPCE, is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from epilepsy. Partners Mark Weeks and Seth Gottlieb led the Cooley team.

Related contacts

Mark Weeks
Partner, Palo Alto
Seth Gottlieb
Partner, Palo Alto
Brett White
Of Counsel, Palo Alto
Noel Ripberger-Scheick
Associate, Palo Alto
John T. Stellini
Associate, Palo Alto

Related Practices & Industries

View more

Rankings & accolades

Chambers USA: Life Sciences: Corporate/Commercial – California (2020 – 2023)

Adept at representing and advising emerging life sciences companies throughout their growth, from pre-incorporation to M&A.

Chambers USA: Life Sciences: Corporate/Commercial – California (2022)